Bromonordiazepam 2mg per ml x 30ml
Firstly, Bromonordiazepam is the active metabolite of the prodrug Gidazepam or Desalkygidazepam which is structurally similar to Nordiazepam. It was introduced into clinical practice in Russia in 1997. Above all, Bromonordiazepam acts as an anxiolyitic. To clarify, anxiolytic is a medication or other intervention that can potentially reduce anxiety.
How Bromonordiazepam works:
Secondly, Bromonordiazepam interacts with receptors and increases the sensitivity of GABA receptors to the mediator. In addition, it increases the inhibitory effect of GABA in the central nervous system. Another key point, its half-life is among the longest of all GABA-ergic agonists. Lastly, it potentially reduces the excitability of the subcortical structures of the brain and inhibits polysynaptic spinal reflexes.
- eliminates the psychic and somatic symptoms of anxiety, uneasiness, stress, as well as combining the anxiolytic characteristics with the activating and antidepressant effects
- even more, it has therapeutic value in the management of certain cardiovascular disorders
- Molecular Formula: C15H11BrN2O
- Molecular Mass: 315.16
Chemical Name: 7-bromo-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
Bromonordiazepam 2mg is available now at Ultra Peptides.
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research, to be handled by qualified and licensed professionals, in laboratory settings only. Bodily introduction or injection of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.